USE OF THE GK-1 PEPTIDE AS AN ANTITUMORAL AND/OR ANTIMETASTATIC AGENT

The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional c...

Full description

Saved in:
Bibliographic Details
Main Authors FRAGOSO GONZÁLEZ, Gladis Del Carmen, TORRES GARCÍA, Diana, MANUCHARYAN, Karen, SEGURA VELÁZQUEZ, René Alvaro, PÉREZ TORRES, Armando, CERVANTES TORRES, Jacquelynne Brenda, SCIUTTO CONDE, Edda Lydia
Format Patent
LanguageEnglish
French
German
Published 27.04.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.
Bibliography:Application Number: EP20170799725